Oxalite capsules 406 g, 60 pcs.

OXALITH is a complex of biologically active components, the combination of which favorably influences various body systems preventing the occurrence of urolithiasis and, first of all, oxalate stones. Components of the drug “OXALITH” reduce allocation of stones and change the molecular structure of the resulting crystals. This leads to slowing down the growth of oxalate stones, prevents their attachment to the cells of the urinary tract and also facilitates retraction of the already existing concrements.

Characteristics of the components of “OXALITH” complex

Lots of medical literature* have confirmed the effectiveness and safety of the components composing the “OXALITH” complex with respect to the prevention and treatment of urolithiasis:

Fucus vesiculosus (Fucusvesiculosus)

• Can reduce oxalate concentration in blood and urine
• Can reduce calcium excretion with urineFucoidan, contained in Fucus extract, increases the concentration of lithogenesis inhibitors in the urine – substances that block the process of “stone formation.The fucoidan contained in the Fucus extract has the unique effect of reducing the likelihood of calcium oxalate crystals attaching to the epithelial cells of the urinary tubules

Phyllanthusniruri

• Limits the number and weight of calcium-oxalate stones formed
• Regulates calcium metabolism in patients with hypercalciuria (increased urinary calcium excretion), significantly reducing its excretion
• CalciumNiruri.
• Limits the growth rate of calcium oxalate crystals
• In existing stones, makes them smoother in shape and less hard, making them much easier to remove from the urinary tract
• Can reduce the incidence of recurrent stone formation and the need for remote lithotripsy (DLT)

Desmodium (Desmodiumstyracifolium)

• Limits the size of calcium-oxalate particles formed
• Prevents the formation of calcium oxalate crystals by increasing urinary excretion of citrate and the formation of soluble calcium citrate, which is easily excreted with urine

* Sources of medical literature:

Barrosetal. UrolRes. 2006 Dec;34(6):351-7. DOI: 10.1007/s00240-006-0065-1

Micali et al. J Urol. 2006 Sep;176(3):1020-2.DOI: 10.1016/j.juro.2006.04.010

NishiuraJL et al. Urol Res. 2004 Oct;32(5):362-6. DOI: 10.1007/s00240-004-0432-8

Freitas AM et al. BJU Int. 2002; 89: 829-34

Veenaetal. JPP 2007, 59: 419-427. DOI: 10.1211/jpp.59.3.0012

Sujatha et al. IntBraz J Urol. 2015 May-Jun;41(3):511-20. doi: 10.1590/S1677-5538.IBJU.2014.0357

Mi J etal. Urol Res. 2012 Apr;40(2):151-61. doi:10.1007/s00240-011-0401-y

Xiang et al. Urolithiasis. 2015 Oct;43(5):433-9. doi: 10.1007/s00240-015-0795-z

Indications

How to take, the dosage

Adults take 1 capsule 2 times a day with meals. The duration of intake – 1 month. If necessary, the reception can be repeated.

The daily dose of 2 capsules contains:

Ingredient

Content in daily dose at least, mg

% of recommended*/adequate** intake level

Fucoidan

50

100(**)

/td>

Iodine

30mcg

20*

*According to ТР ТС ТС 022/2011

**Consistent with “Uniform Sanitary Epidemiological and Hygienic Requirements for Goods Subject to Sanitary and Epidemiological Supervision (Control)

Special Instructions

Contraindications